American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

September 07, 2021

Newsletter Sponsor

Solving solubility challenges: How to overcome the most common limitations in drug development

Around 90 percent of drug candidates in clinical development are poorly soluble. Evonik Health Care is a drug delivery solutions provider with a proven track record of helping customers choose the right functional polymer, process technology and formulation to speed up time-to-market.

In Evonik’s upcoming webinar on September 22, the drug delivery experts Thomas Endres and Priyanka Haksar of Evonik Health Care will explain how EUDRAGIT® functional polymers improve drug solubility and permeability to achieve the desired release profile of oral dosage forms.

	Industry News

Thermo Fisher Scientific Awarded $192.5 Million U.S. Government Contract to Expand Domestic Pipette Tip Manufacturing
Thermo Fisher Scientific Inc., the world leader in serving science, announced a $192.5 million ... read more »

FDA Grants BRUKINSA® (Zanubrutinib) Approval in Waldenström’s Macroglobulinemia
BeiGene Ltd, a global biotechnology company focused on developing and commercializing innovative ... read more »

Scopus BioPharma Launches Duet Therapeutics
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company developing transformational ... read more »

Takeda Provides Update on Phase 3 PANTHER (Pevonedistat-3001) Trial
Takeda Pharmaceutical Company Limited announced that the Phase 3 PANTHER (Pevonedistat-3001) study ... read more »

	Infographic

6 Reasons to Switch to Automated Titration
If you still perform titrations the old-fashioned way (by hand), you are not alone. Learn how automation can improve not just sample throughput, but... read more »

	Featured Articles

New Expectations for Training – Tied to Implementation of Contamination Control Strategies With the upcoming implementation of the revised Annex 1 of the European Union GMPs, many companies are developing contamination control strategies. ... read more »

Quantification of Residual Host Cell DNA in Protamine Sulfate Drug Product Using Droplet Digital PCR Protamine Sulfate (ProS) is the only FDA approved anticoagulation reversal agent for unfractionated heparin. ProS is biologically derived from chum ... read more »

	Featured Video

On-Demand Webinar: Development and Validation of a Platform Assay Method Using Variable Pathlength Technology for Oligonucleotide Drug Products
This webinar will share Ionis’ experience with developing and validating a platform SoloVPE® in-process assay method for GMP manufacturing of ... watch »

On-Demand Webinar: Validation of a Mycoplasma NAT Platform for Product Release in Cell Therapy
This webinar will provide a review of validation strategies and implementation for a rapid at-line mycoplasma test for cell therapy companies. watch »

	Featured Products

Nicomp® Nano DLS/ZLS Systems
read more »

	Featured Whitepaper

eBook: BET Automation Simplified: How to achieve simple, automated endotoxin testing
To succeed and thrive in today’s pharmaceutical QC environment, it is critical to increase efficiency while maintaining compliance. The need to quickly and accurately test samples, review data, and ... read more »

	Events

Wearable Injectors and Connected Devices Conference 2021
London, UK – 10/18/2021
SMi’s 2nd annual Wearable Injectors and Connected Devices Conference will explore real world case studies of on-body device design and development for... event details »

Ophthalmic Drugs Conference
London, UK – 11/22/2021
The global ophthalmic drug market is forecast to surpass $60 billion USD by 2025 with increasing focus from the industry on alternative delivery ... event details »

This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription | Unsubscribe | Contact American Pharmaceutical Review

American Pharmaceutical Review
164 Townsend St. Unit 2
San Francisco, CA 94107 USA